745017-94-1,MFCD25976742
Catalog No.:AA003574

745017-94-1 | Monomethyl Auristatin F

Pack Size
Purity
Availability
Price(USD)
Quantity
  
2mg
98%
in stock  
$19.00   $14.00
- +
5mg
98%
in stock  
$36.00   $25.00
- +
100mg
95%
in stock  
$525.00   $368.00
- +
250mg
95%
in stock  
$779.00   $545.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA003574
Chemical Name:
Monomethyl Auristatin F
CAS Number:
745017-94-1
Molecular Formula:
C39H65N5O8
Molecular Weight:
731.9621
MDL Number:
MFCD25976742
SMILES:
CN[C@H](C(=O)N[C@H](C(=O)N(C([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@H](C(=O)N[C@H](C(=O)O)Cc1ccccc1)C)OC)OC)[C@H](CC)C)C)C(C)C)C(C)C
Properties
Properties
 
Form:
Solid  
MP:
>137°C (dec.)  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
1160  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
9  
Heavy Atom Count:
52  
Hydrogen Bond Acceptor Count:
9  
Hydrogen Bond Donor Count:
4  
Rotatable Bond Count:
21  
XLogP3:
2.1  

Literature

Title: Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues.

Journal: Analytical chemistry 20120320

Title: Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in rats.

Journal: Bioconjugate chemistry 20111019

Title: Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selection.

Journal: Cancer research 20090315

Title: A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.

Journal: Cancer research 20081115

Title: Anti-CD22-MCC-DM1 and MC-MMAF conjugates: impact of assay format on pharmacokinetic parameters determination.

Journal: Bioconjugate chemistry 20080801

Title: Lee JW, et al. EphA2 targeted chemotherapy using an antibody drug conjugate in endometrial carcinoma. Clin Cancer Res. 2010 May 1;16(9):2562-70.

Title: Lee JJ, et al. Enzymatic prenylation and oxime ligation for the synthesis of stable and homogeneous protein-drug conjugates for targeted therapy. Angew Chem Int Ed Engl. 2015 Oct 5;54(41):12020-4.

Title: Kim EG, et al. Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted CancerTherapeutics.

Title: Doronina SO, et al. Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity. Bioconjug Chem. 2006 Jan-Feb;17(1):114-24.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:745017-94-1 Molecular Formula|745017-94-1 MDL|745017-94-1 SMILES|745017-94-1 Monomethyl Auristatin F
Catalog No.: AA003574
745017-94-1,MFCD25976742
745017-94-1 | Monomethyl Auristatin F
Pack Size: 2mg
Purity: 98%
in stock
$19.00 $14.00
Pack Size: 5mg
Purity: 98%
in stock
$36.00 $25.00
Pack Size: 100mg
Purity: 95%
in stock
$525.00 $368.00
Pack Size: 250mg
Purity: 95%
in stock
$779.00 $545.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA003574
Chemical Name: Monomethyl Auristatin F
CAS Number: 745017-94-1
Molecular Formula: C39H65N5O8
Molecular Weight: 731.9621
MDL Number: MFCD25976742
SMILES: CN[C@H](C(=O)N[C@H](C(=O)N(C([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@H](C(=O)N[C@H](C(=O)O)Cc1ccccc1)C)OC)OC)[C@H](CC)C)C)C(C)C)C(C)C
Properties
Form: Solid  
MP: >137°C (dec.)  
Storage: Keep in dry area;2-8℃;  
Complexity: 1160  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 9  
Heavy Atom Count: 52  
Hydrogen Bond Acceptor Count: 9  
Hydrogen Bond Donor Count: 4  
Rotatable Bond Count: 21  
XLogP3: 2.1  
Literature fold

Title: Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues.

Journal: Analytical chemistry20120320

Title: Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in rats.

Journal: Bioconjugate chemistry20111019

Title: Antibody-drug conjugates for the treatment of non-Hodgkin's lymphoma: target and linker-drug selection.

Journal: Cancer research20090315

Title: A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo.

Journal: Cancer research20081115

Title: Anti-CD22-MCC-DM1 and MC-MMAF conjugates: impact of assay format on pharmacokinetic parameters determination.

Journal: Bioconjugate chemistry20080801

Title: Lee JW, et al. EphA2 targeted chemotherapy using an antibody drug conjugate in endometrial carcinoma. Clin Cancer Res. 2010 May 1;16(9):2562-70.

Title: Lee JJ, et al. Enzymatic prenylation and oxime ligation for the synthesis of stable and homogeneous protein-drug conjugates for targeted therapy. Angew Chem Int Ed Engl. 2015 Oct 5;54(41):12020-4.

Title: Kim EG, et al. Strategies and Advancement in Antibody-Drug Conjugate Optimization for Targeted CancerTherapeutics.

Title: Doronina SO, et al. Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity. Bioconjug Chem. 2006 Jan-Feb;17(1):114-24.

Building Blocks More >
84358-13-4
84358-13-4
N-Boc-piperidine-4-carboxylic acid
AA0035AE | MFCD00076999
471-46-5
471-46-5
Oxamide
AA0035D3 | MFCD00008007
79-09-4
79-09-4
Propionic acid
AA0035G8 | MFCD00002756
112-76-5
112-76-5
Stearoyl chloride
AA0035JI | MFCD00000744
62086-04-8
62086-04-8
Tin(ii) trifluoromethanesulfonate
AA0035MG | MFCD00191251
4325-85-3
4325-85-3
Tris(trimethylsilyl) borate
AA0035PC | MFCD00051588
109-63-7
109-63-7
boron trifluoride ethyl ether
AA0035SP | MFCD00013194
7646-69-7
7646-69-7
Sodium hydride
AA0035VQ | MFCD00003471
62234-40-6
62234-40-6
Z-Dab-oh
AA0035YW | MFCD00077904
4607-41-4
4607-41-4
3-(3-Hydroxyphenyl)-2-oxopropanoic acid
AA00362C | MFCD09742286
Submit
© 2017 AA BLOCKS, INC. All rights reserved.